Home/Filings/4/0001209191-22-015201
4//SEC Filing

Sims Andrew John Hugh MacIntyre 4

Accession 0001209191-22-015201

CIK 0001095981other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 6:15 AM ET

Size

5.3 KB

Accession

0001209191-22-015201

Insider Transaction Report

Form 4
Period: 2022-03-01
Sims Andrew John Hugh MacIntyre
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-03-01$1.10/sh+2,000$2,2009,230 total
Footnotes (1)
  • [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices of $1.0998 or $1.00 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

PLUS THERAPEUTICS, INC.

CIK 0001095981

Entity typeother

Related Parties

1
  • filerCIK 0001802687

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:15 AM ET
Size
5.3 KB